273 related articles for article (PubMed ID: 9665753)
1. Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation.
Mannie MD; Nardella JP; White GA; Arnold PY; Davidian DK
Cell Immunol; 1998 Jun; 186(2):111-20. PubMed ID: 9665753
[TBL] [Abstract][Full Text] [Related]
2. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
3. Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen-presenting cells.
Arnold PY; Davidian DK; Mannie MD
Eur J Immunol; 1997 Dec; 27(12):3198-205. PubMed ID: 9464806
[TBL] [Abstract][Full Text] [Related]
4. MHC class-II-restricted antigen presentation by myelin basic protein-specific CD4+ T cells causes prolonged desensitization and outgrowth of CD4- responders.
Mannie MD; Norris MS
Cell Immunol; 2001 Aug; 212(1):51-62. PubMed ID: 11716529
[TBL] [Abstract][Full Text] [Related]
5. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition.
Mannie MD; Rosser JM; White GA
J Immunol; 1995 Mar; 154(6):2642-54. PubMed ID: 7533179
[TBL] [Abstract][Full Text] [Related]
6. Feedback activation of T-cell antigen-presenting cells during interactions with T-cell responders.
Mannie MD; Walker MR
J Leukoc Biol; 2001 Aug; 70(2):252-60. PubMed ID: 11493617
[TBL] [Abstract][Full Text] [Related]
7. MHC class II biosynthesis by activated rat CD4+ T cells: development of repression in vitro and modulation by APC-derived signals.
Mannie MD; Dawkins JG; Walker MR; Clayson BA; Patel DM
Cell Immunol; 2004 Jul; 230(1):33-43. PubMed ID: 15541717
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells.
Jemmerson R; Johnson JG; Burrell E; Taylor PS; Jenkins MK
Eur J Immunol; 1991 Jan; 21(1):143-51. PubMed ID: 1846813
[TBL] [Abstract][Full Text] [Related]
9. Intercellular exchange of class II MHC complexes: ultrastructural localization and functional presentation of adsorbed I-A/peptide complexes.
Patel DM; Dudek RW; Mannie MD
Cell Immunol; 2001 Nov; 214(1):21-34. PubMed ID: 11902826
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of encephalitogenic T cells confers resistance to an inhibitory anti-CD4 monoclonal antibody.
Mannie MD; Morrison-Plummer J; McConnell TJ
J Immunol; 1993 Dec; 151(12):7293-306. PubMed ID: 7505025
[TBL] [Abstract][Full Text] [Related]
11. Activation of specific T cell lines by the antigens avidin and myelin basic protein in the absence of antigen-presenting cells.
Altmann DM; Lider O; Douek DC; Cohen IR
Eur J Immunol; 1987 Nov; 17(11):1635-40. PubMed ID: 2445586
[TBL] [Abstract][Full Text] [Related]
12. Intercellular exchange of class II major histocompatibility complex/peptide complexes is a conserved process that requires activation of T cells but is constitutive in other types of antigen presenting cell.
Patel DM; Mannie MD
Cell Immunol; 2001 Dec; 214(2):165-72. PubMed ID: 12088415
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
14. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
[TBL] [Abstract][Full Text] [Related]
15. Antigen presentation in the rat. II. An Ia+ radiosensitive T cell can present antigen to primed Ia- T cells.
Sopori ML; Cohen DA; Cherian S; Perrone RS; Kaplan AM
J Immunol; 1985 Mar; 134(3):1369-73. PubMed ID: 3155764
[TBL] [Abstract][Full Text] [Related]
16. Role of ICAM-1 in antigen presentation demonstrated by ICAM-1 defective mutants.
Dang LH; Michalek MT; Takei F; Benaceraff B; Rock KL
J Immunol; 1990 Jun; 144(11):4082-91. PubMed ID: 1971292
[TBL] [Abstract][Full Text] [Related]
17. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
18. Lewis rat T cells can reutilize, process, and present myelin basic protein to antigen-specific T cell lines.
St Louis JM; Pasick JM; Stein C; Freeman D; Singh B; Dales S; Strejan GH
Cell Immunol; 1994 Jun; 156(1):36-53. PubMed ID: 7515332
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
Adorini L; Ullrich SJ; Appella E; Fuchs S
Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
[TBL] [Abstract][Full Text] [Related]
20. The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide.
Gradehandt G; Kleber N; Mattner F; Milbradt S; Rüde E
Immunology; 1993 Apr; 78(4):592-9. PubMed ID: 8495978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
